Lupus Erythematosis
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus (NCT06468683) | Shanghai Simnova Biotechnology Co.,Ltd. | 2024-06-15 |
Track Lupus Erythematosis automatically
Every clearance here is in the API, with alerts when new ones post.